Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 1
2018 2
2019 2
2020 7
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). Munzone E, et al. JAMA Oncol. 2023 Sep 1;9(9):1267-1272. doi: 10.1001/jamaoncol.2023.2150. JAMA Oncol. 2023. PMID: 37440239 Clinical Trial.
Retinal Changes Induced by Epiretinal Tangential Forces.
Romano MR, Comune C, Ferrara M, Cennamo G, De Cillà S, Toto L, Cennamo G. Romano MR, et al. Among authors: comune c. J Ophthalmol. 2015;2015:372564. doi: 10.1155/2015/372564. Epub 2015 Sep 3. J Ophthalmol. 2015. PMID: 26421183 Free PMC article. Review.
Reshaping ophthalmology training after COVID-19 pandemic.
Ferrara M, Romano V, Steel DH, Gupta R, Iovino C, van Dijk EHC; OphthaTraining Group; Romano MR. Ferrara M, et al. Eye (Lond). 2020 Nov;34(11):2089-2097. doi: 10.1038/s41433-020-1061-3. Epub 2020 Jul 1. Eye (Lond). 2020. PMID: 32612174 Free PMC article.
An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011.
Bonavolontà G, Strianese D, Grassi P, Comune C, Tranfa F, Uccello G, Iuliano A. Bonavolontà G, et al. Among authors: comune c. Ophthalmic Plast Reconstr Surg. 2013 Mar-Apr;29(2):79-86. doi: 10.1097/IOP.0b013e31827a7622. Ophthalmic Plast Reconstr Surg. 2013. PMID: 23470516 Review.
Methotrexate for the treatment of thyroid eye disease.
Strianese D, Iuliano A, Ferrara M, Comune C, Baronissi I, Napolitano P, D'Alessandro A, Grassi P, Bonavolontà G, Bonavolontà P, Sinisi A, Tranfa F. Strianese D, et al. Among authors: comune c. J Ophthalmol. 2014;2014:128903. doi: 10.1155/2014/128903. Epub 2014 Jan 8. J Ophthalmol. 2014. PMID: 24678411 Free PMC article.
17 results